Animal treatments
Compositions and methods for the treatment and control of various conditions in an animal which comprises administering to said animal an effective amount of a immediate release composition of about 0.5% to 50% wt/wt of active ingredient together with excipients to a total of about 100%, wherein said composition dissolves in a relatively short period of time, e.g., 75 seconds or less, 5 seconds or less, or 3 seconds or less, upon administration to said animal.
1. A method of treating recurrent airway inflammation in an animal in need thereof, the method comprising:
determining a dose of clenbuterol required; and
administering orally to a pre-gastric mucosal cell of the animal a Direct Systemic Introduction (DSI) composition comprising clenbuterol,
wherein the DSI composition in the animal's oral cavity is dissolved in less than about 75 seconds, and
wherein the required dose of clenbuterol is determined by greater than 50% of the administered clenbuterol being detected in the animal's circulatory system via the pre-gastric mucosal cells lining the animal's alimentary canal prior to the animal's secretory stomach.
2. The method according to claim 1 , wherein the DSI composition is dissolved in less than about 30 seconds.
3. The method according to claim 1 , wherein the DSI composition is dissolved in less than about 5 seconds.
4. The method according to claim 1 , wherein the clenbuterol is present in the DSI composition in an amount ranging from about 0.5% to about 50% by weight of the overall composition.
5. The method according to claim 1 , wherein the clenbuterol is in the form of a free base; a water soluble salt; or an isolated single enantiomer or mixture thereof.
6. The method according to claim 1 , wherein the animal is human.
7. The method according to claim 1 , wherein the animal is an equine.
8. The method according to claim 1 , wherein the DSI composition further comprises at least one excipient.
9. The method according to claim 1 , wherein the DSI composition provides an immediate release of clenbuterol.
10. The method according to claim 1 , wherein the DSI composition is in the form of a tablet comprising about 0.36 mg of clenbuterol.
11. The method according to claim 1 , wherein the DSI composition is formulated to provide about 0.2 mcg/kg to about 3.0 mcg/kg of clenbuterol per body weight of the animal.
12. A method of treating a central nervous system disorder in an animal in need thereof, the method comprising:
determining a dose of clenbuterol required; and
administering orally to a pre-gastric mucosal cell of the animal a Direct Systemic Introduction (DSI) composition comprising clenbuterol,
wherein the DSI composition in the animal's oral cavity is dissolved in less than about 75 seconds, and
wherein the required dose of clenbuterol is determined by greater than 50% of the administered clenbuterol being detected in the animal's circulatory system via the pre-gastric mucosal cells lining the animal's alimentary canal prior to the animal's secretory stomach.
13. The method according to claim 12 , wherein the central nervous system disorder is Parkinson's Disease.
14. The method according to claim 12 , wherein the DSI composition is dissolved in less than about 30 seconds.
15. The method according to claim 12 , wherein the DSI composition is dissolved in less than about 5 seconds.
16. The method according to claim 12 , wherein the clenbuterol is present in the DSI composition in an amount ranging from about 0.5% to about 50% by weight of the overall composition.
17. The method according to claim 12 , wherein the clenbuterol is in the form of a free base; a water soluble salt; or an isolated single enantiomer or mixture thereof.
18. The method according to claim 12 , wherein the animal is human.
19. The method according to claim 12 , wherein the animal is an equine.
20. The method according to claim 12 , wherein the DSI composition further comprises at least one excipient.
21. The method according to claim 12 , wherein the DSI composition provides an immediate release of clenbuterol.